Business Context and Reporting Period
This Form 8-K filing by Obalon Therapeutics, Inc. (not Vyome Holdings, Inc.) reports on the results of the 2017 Annual Meeting of Stockholders held on June 6, 2017. The report was filed on June 7, 2017.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance voting results.
Material Changes
No material financial changes are reported in this filing. The document details the final voting outcomes for two proposals submitted to security holders.
Guidance, Outlook, and Management Commentary
The filing contains no guidance, outlook, or management commentary regarding future operations. It confirms the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2017.
Important Facts for Investors to Verify
- Director Election Results: Stockholders elected Douglas Fisher, M.D., and Sharon Stevenson, DVM Ph.D., as Class I Directors for a term expiring at the 2020 annual meeting.
- Vote Totals for Directors:
- Douglas Fisher: 10,851,642 votes for; 1,274,041 votes withheld.
- Sharon Stevenson: 10,910,488 votes for; 1,215,195 votes withheld.
- Auditor Ratification: KPMG LLP was ratified with 13,309,404 votes for, 1,600 votes against, and 2,352 abstentions.
- Broker Non-Votes: There were 1,187,673 broker non-votes for the director election and 0 for the auditor ratification.